美国 · 财经报刊 · Investor's Business Daily
Regeneron, Sanofi Surge As Dupixent Wallops Sales Forecasts
Regeneron stock popped Thursday after its Sanofi-partnered allergic conditions drug, Dupixent, easily beat third-quarter calls. The post Regeneron, Sanofi Surge As Dupixent…
在 Investor's Business Daily 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.investors.com)